Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
09-11 April, 2025
Not Confirmed
Not Confirmed
29-30 March, 2025
Not Confirmed
Not Confirmed
31 March-01 April, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
09-11 April, 2025
Industry Trade Show
Not Confirmed
29-30 March, 2025
Industry Trade Show
Not Confirmed
31 March-01 April, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/molecular-glue-degraders-lilly-abbvie-sign-billion-dollar-deals-bms-leads-with-three-late-stage-drugs
10 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/aileron-therapeutics-announces-rebranding-to-rein-therapeutics-302348094.html
14 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/aileron-therapeutics-reports-third-quarter-2024-financial-results-and-recent-business-highlights-302306387.html
13 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/aileron-therapeutics-announces-positive-topline-data-from-cohort-2-of-the-phase-1b-clinical-trial-of-lti-03-in-idiopathic-pulmonary-fibrosis-ipf-302303568.html
31 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/aileron-therapeutics-and-advancium-health-network-announce-an-exclusive-option-agreement-for-the-acquisition-of-alrn-6924-for-retinoblastoma-302292196.html
12 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/aileron-therapeutics-to-present-previously-announced-data-from-the-phase-1b-clinical-trial-evaluating-low-dose-lti-03-in-idiopathic-pulmonary-fibrosis-ipf-at-the-22nd-international-colloquium-on-lung-and-airway-fibrosis-302274268.html
23 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/aileron-therapeutics-completes-enrollment-in-cohort-2-of-the-ongoing-phase-1b-clinical-trial-evaluating-lti-03-in-idiopathic-pulmonary-fibrosis-ipf-302254831.html
ABOUT THIS PAGE